Guggenheim Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.47M | Sell |
10,649
-1,718
| -14% | -$560K | 0.03% | 513 |
|
2025
Q1 | $3.34M | Sell |
12,367
-416
| -3% | -$112K | 0.03% | 516 |
|
2024
Q4 | $3.01M | Sell |
12,783
-2,465
| -16% | -$580K | 0.02% | 537 |
|
2024
Q3 | $4.19M | Sell |
15,248
-3,939
| -21% | -$1.08M | 0.03% | 584 |
|
2024
Q2 | $4.66M | Sell |
19,187
-1,975
| -9% | -$480K | 0.03% | 544 |
|
2024
Q1 | $3.16M | Buy |
21,162
+3,411
| +19% | +$510K | 0.02% | 728 |
|
2023
Q4 | $3.4M | Buy |
17,751
+507
| +3% | +$97K | 0.03% | 664 |
|
2023
Q3 | $3.05M | Sell |
17,244
-2,422
| -12% | -$429K | 0.03% | 664 |
|
2023
Q2 | $3.74M | Sell |
19,666
-320
| -2% | -$60.8K | 0.03% | 631 |
|
2023
Q1 | $4M | Sell |
19,986
-831
| -4% | -$166K | 0.03% | 603 |
|
2022
Q4 | $4.95M | Buy |
20,817
+1,560
| +8% | +$371K | 0.04% | 532 |
|
2022
Q3 | $3.85M | Sell |
19,257
-6,092
| -24% | -$1.22M | 0.04% | 592 |
|
2022
Q2 | $3.7M | Sell |
25,349
-395
| -2% | -$57.6K | 0.03% | 665 |
|
2022
Q1 | $4.2M | Sell |
25,744
-561
| -2% | -$91.6K | 0.03% | 714 |
|
2021
Q4 | $4.46M | Buy |
26,305
+2,461
| +10% | +$417K | 0.02% | 728 |
|
2021
Q3 | $4.5M | Sell |
23,844
-2,093
| -8% | -$395K | 0.03% | 704 |
|
2021
Q2 | $4.4M | Sell |
25,937
-3,501
| -12% | -$594K | 0.03% | 722 |
|
2021
Q1 | $4.16M | Sell |
29,438
-2,205
| -7% | -$311K | 0.03% | 710 |
|
2020
Q4 | $4.11M | Sell |
31,643
-6,401
| -17% | -$832K | 0.03% | 666 |
|
2020
Q3 | $5.54M | Sell |
38,044
-7,104
| -16% | -$1.03M | 0.04% | 485 |
|
2020
Q2 | $6.69M | Buy |
45,148
+3,330
| +8% | +$493K | 0.05% | 401 |
|
2020
Q1 | $4.55M | Sell |
41,818
-9,187
| -18% | -$1M | 0.05% | 476 |
|
2019
Q4 | $5.87M | Buy |
51,005
+315
| +0.6% | +$36.3K | 0.04% | 540 |
|
2019
Q3 | $4.08M | Sell |
50,690
-7,433
| -13% | -$598K | 0.03% | 685 |
|
2019
Q2 | $4.22M | Sell |
58,123
-2,134
| -4% | -$155K | 0.03% | 696 |
|
2019
Q1 | $5.63M | Sell |
60,257
-3,717
| -6% | -$347K | 0.05% | 549 |
|
2018
Q4 | $4.66M | Buy |
63,974
+3,473
| +6% | +$253K | 0.04% | 607 |
|
2018
Q3 | $5.3M | Buy |
60,501
+4,680
| +8% | +$410K | 0.03% | 690 |
|
2018
Q2 | $5.5M | Buy |
55,821
+2,737
| +5% | +$270K | 0.04% | 656 |
|
2018
Q1 | $6.32M | Buy |
53,084
+600
| +1% | +$71.5K | 0.02% | 882 |
|
2017
Q4 | $6.67M | Sell |
52,484
-32,983
| -39% | -$4.19M | 0.02% | 884 |
|
2017
Q3 | $10M | Buy |
85,467
+18,094
| +27% | +$2.13M | 0.02% | 679 |
|
2017
Q2 | $5.38M | Sell |
67,373
-17,484
| -21% | -$1.39M | 0.01% | 975 |
|
2017
Q1 | $4.35M | Buy |
84,857
+5,774
| +7% | +$296K | 0.01% | 1109 |
|
2016
Q4 | $2.96M | Buy |
79,083
+4,565
| +6% | +$171K | 0.01% | 1379 |
|
2016
Q3 | $5.05M | Sell |
74,518
-11,850
| -14% | -$803K | 0.02% | 1011 |
|
2016
Q2 | $4.79M | Sell |
86,368
-4,294
| -5% | -$238K | 0.02% | 1028 |
|
2016
Q1 | $5.69M | Sell |
90,662
-23,340
| -20% | -$1.47M | 0.02% | 920 |
|
2015
Q4 | $10.7M | Sell |
114,002
-28,541
| -20% | -$2.69M | 0.03% | 733 |
|
2015
Q3 | $11.5M | Sell |
142,543
-2,220
| -2% | -$178K | 0.04% | 700 |
|
2015
Q2 | $17.4M | Buy |
144,763
+8,423
| +6% | +$1.01M | 0.04% | 642 |
|
2015
Q1 | $14.2M | Buy |
136,340
+22,323
| +20% | +$2.33M | 0.03% | 722 |
|
2014
Q4 | $11.1M | Buy |
114,017
+14,441
| +15% | +$1.4M | 0.03% | 801 |
|
2014
Q3 | $7.78M | Sell |
99,576
-4,254
| -4% | -$332K | 0.02% | 990 |
|
2014
Q2 | $6.56M | Sell |
103,830
-10,627
| -9% | -$671K | 0.02% | 1033 |
|
2014
Q1 | $7.68M | Buy |
114,457
+13,710
| +14% | +$920K | 0.02% | 935 |
|
2013
Q4 | $6.48M | Sell |
100,747
-7,349
| -7% | -$473K | 0.02% | 975 |
|
2013
Q3 | $6.92M | Sell |
108,096
-73,320
| -40% | -$4.69M | 0.02% | 947 |
|
2013
Q2 | $5.63M | Buy |
+181,416
| New | +$5.63M | 0.02% | 1000 |
|